Related Experiment Video

Updated: Aug 7, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Commentary on journal of immunotherapy paper by melenhorst et al

Helen E Heslop

    Journal of Immunotherapy (Hagerstown, Md. : 1997)
    |June 27, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intralymphatic Immunotherapy and Vaccination in Mice
    07:33

    Intralymphatic Immunotherapy and Vaccination in Mice

    Published on: February 2, 2014

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    Related Experiment Videos

    Last Updated: Aug 7, 2026

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
    09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    Intralymphatic Immunotherapy and Vaccination in Mice
    07:33

    Intralymphatic Immunotherapy and Vaccination in Mice

    Published on: February 2, 2014

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    Related Concept Videos

    Cell-mediated Immune Responses01:40

    Cell-mediated Immune Responses

    Overview
    Humoral Immune Responses01:36

    Humoral Immune Responses

    Overview
    What is the Immune System?01:38

    What is the Immune System?

    Overview

    Articles linked to this work by shared authors, journal, and citation graph.

    Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.

    Transplantation and cellular therapy·2026

    Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

    Nature medicine·2026

    Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma.

    Nature medicine·2025

    Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.

    Blood advances·2025

    Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.

    Nature·2024

    Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.

    Transplantation and cellular therapy·2024

    Armoring CAR-T Cells Against Exhaustion: Engineering Strategies for Glioblastoma.

    Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

    Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

    Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

    IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway.

    Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

    Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.

    Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

    Identifying Patients at Risk for Immune Checkpoint Inhibitor-Induced Colitis: Evidence From a Real-World Oncology Cohort.

    Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

    Internalization-Dependent EGFR-Targeted Photoactivation by Cetuximab-I21 Conjugates.

    Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

    Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

    Diabetes, metabolic syndrome and obesity : targets and therapy·2026

    The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

    Case reports in immunology·2026

    Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us